Invitation to press and analyst briefing on the Year-End Report

Wednesday, February 14, 10:00 a.m, (CET) at Operaterrassen, Stockholm.

Bengt Ågerup, CEO and Erika Kjellberg Eriksson, CFO, will present the company and comment on the report.

Moderator: Lars Hevreng, Enskilda Securites.

To participate, please register in one of the following ways: at www.financialhearings.com, or mail hearings@financialhearings.com or by phone
+ 46(0) 8 411 43 80.

Wednesday’s presentation can also be followed live by telephone conference, which is accessible by dialling + 44 (0) 20 7806 1966 or Web Cast Live at. www.financialhearings.com or www.q-med.com. The slide presentation will be available at www.q-med.com, on Wednesday, February 14 at the latest 10.00 a.m.

Q-Med’s year-end report will be published around 08:00 a.m Wednesday,
February 14.

Financial information from Q-Med during Year 2007:

3 May Interim Report January – March 2007
3 May Annual General Meeting
26 July Interim Report January – June 2007
23 October Interim Report January - September 2007


Queries should be addressed to: Camilla Schartau, Administrative Assistant
Tel: +46 (0) 733 87 14 22

About Us

Q-Med is a rapidly growing and profitable biotechnology and medical device company that develops, produces and markets medical implants. Operations focus on four areas, Esthetics, Orthopedics, Uro-Gynecology, and Cell Therapy and Encapsulation.

Subscribe

Documents & Links